National Institutes of Health: all 11,571 studies

Page 43 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Effect of Ketamine on Fatigue Following Cancer TherapyTerminatedNCT02317341Early Phase 1
• Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell MalignanciesCompletedNCT02315612Phase 1
• Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary FibrosisCompletedNCT02315586
• Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or GliosarcomaCompletedNCT02311920Phase 1
• A Randomized Prospective Clinical Trial of Fel d 1 Peptide ImmunotherapyCompletedNCT02311413Phase 2
• Self-Affirmation, Emotion, and Alcohol ConsumptionCompletedNCT02311400
• Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, MaliCompletedNCT02311387
• Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and WakefulnessCompletedNCT02311374Early Phase 1
• Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver BiopsyCompletedNCT02311348
• Genes Involved in Lipid DisordersCompletedNCT02311335
• Genetic Causes of Growth DisordersTerminatedNCT02311322
• TODAY2 Phase 2 Follow-upCompletedNCT02310724
• Prospective International Study of Coronary Subtraction Using 320 Detector Row CT (CorSub)CompletedNCT02303067
• Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerActive, not recruitingNCT02298959Phase 1
• Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected AdultsCompletedNCT02296541Phase 1
• Minority Health Genomics and Translational Research Bio-Repository Database (MH-GRID)-2.0CompletedNCT02290392
• Frequency and Complications of Major Orthopedic Procedures in Medicare BeneficiariesActive, not recruitingNCT02281747
• Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic AccessCompletedNCT02280824Phase 1
• Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years OldCompletedNCT02274545Phase 1
• Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyActive, not recruitingNCT02262832Phase 3
• Human Immunity Against Staphylococcus Aureus Skin InfectionCompletedNCT02262819Phase 1
• Compassionate Use of Metreleptin in Previously Treated People With Partial LipodystrophyActive, not recruitingNCT02262806Phase 2
• DHB Supplement Interaction StudyWithdrawnNCT02257879
• Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) RecipientsCompletedNCT02257853Phase 2
• Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 StudyCompletedNCT02255123
• A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus VaccineCompletedNCT02251288Phase 1
• Improving Cervical Cancer Screening Among HIV-Infected Women in IndiaCompletedNCT02247999
• Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral DisorderWithdrawnNCT02247986Phase 1/2
• Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to TreatmentActive, not recruitingNCT02243592
• Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral ProductsCompletedNCT02242968
• Imaging Techniques in CT: Technical DevelopmentTerminatedNCT02242448
• Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and ChildrenCompletedNCT02237209Phase 1
• Iloprost in Preventing Lung Cancer in Former SmokersCompletedNCT02237183Phase 1
• Brain Inflammation and Function in AlcoholismCompletedNCT02233868Early Phase 1
• People Presenting With Neurocysticercosis in North AmericaTerminatedNCT02233855
• Dopamine Rhythms in Health and AddictionWithdrawnNCT02233829Early Phase 1
• Evaluating the Transition From Pediatric to Adult Care Among Adolescents With Chronic Granulomatous DiseaseCompletedNCT02233036
• Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy AdultsCompletedNCT02231866Phase 1
• Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral InfectionsTerminatedNCT02231853Phase 1
• PET Imaging of Brain mGluR1 Receptors Using [18F]FIMXCompletedNCT02230592
• Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated LymphomasWithdrawnNCT02228512Phase 1/2
• Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT02227901Phase 1
• Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation RadiationCompletedNCT02226874
• Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell TransplantationCompletedNCT02226861Phase 1
• Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in People With Persistent Symptoms During the Subacute Period After Traumatic Brain InjuryWithdrawnNCT02226848Phase 2
• Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198TerminatedNCT02226835
• Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African AmericansCompletedNCT02225184
• Physicians' Experiences With and Attitudes Toward Non-Medical Sex Selection Through Preimplantation Genetic DiagnosisCompletedNCT02225171
• Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth InfectionTerminatedNCT02225158
• Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell DiseaseCompletedNCT02225145
• The Focal Electro-Oculogram in Macular DiseaseCompletedNCT02225119
• Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaCompletedNCT02219737Phase 1
• Pregnancy Eating Attributes StudyCompletedNCT02217462
• H7N9 Mix and Match With MF59 in Healthy Elderly PersonsCompletedNCT02213354Phase 2
• Impact of Vaccination on Th2 Immunity in InfancyTerminatedNCT02213341
• PET Imaging in Chronic Traumatic EncephalopathyCompletedNCT02211820
• Study of Diets and Way of Life of Native Americans and Hispanics in New Mexico During the Time of the Trinity Nuclear TestCompletedNCT02211781
• Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1CompletedNCT02211768Phase 1
• Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid TumorsCompletedNCT02211755Phase 1
• Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative DisordersCompletedNCT02210858Phase 1/2
• Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected AdultsCompletedNCT02207920Phase 1
• H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...CompletedNCT02206464Phase 1
• Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in MaliCompletedNCT02206451
• Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS LymphomaActive, not recruitingNCT02203526Phase 1
• Metabolic and Neural Adaptations to Weight Loss, Plateau, and RegainWithdrawnNCT02199483
• Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has SpreadActive, not recruitingNCT02196181Phase 2
• Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)Active, not recruitingNCT02194738Not applicable
• Where Does Hope Fit In? The Relationship Between Hope, Uncertainty, and Coping Efficacy in Mothers of Children With Duchenne/Becker Muscular DystrophyCompletedNCT02194725
• Reliability of the Human Brain ConnectomeCompletedNCT02193425Early Phase 1
• Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)Active, not recruitingNCT02193282Phase 3
• Seroprevalence of Hepatitis E in People With an Organ TransplantCompletedNCT02190253
• Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal CancerCompletedNCT02188264Phase 1
• Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of AgeCompletedNCT02186626Phase 1
• Biomarkers for Post-Transplant Lymphoproliferative Disorders in ChildrenCompletedNCT02182986
• Traits Associated With Early Life Stress Among Treatment-Seeking AlcoholicsWithdrawnNCT02181608
• Deep Reading as a Contemplative Practice for Women With Primary Ovarian InsufficiencyTerminatedNCT02181595Phase 1
• Specific PET Radioligand Binding to Translocator ProteinCompletedNCT02181582Phase 1
• Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods StudyCompletedNCT02181569
• Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy SubjectsCompletedNCT02178254Phase 1
• Effects of Cannabis Administration Routes on Human Performance and PharmacokineticsCompletedNCT02177513Phase 1
• Neural Basis of Decision-Making Deficits in Traumatic Brain InjuryCompletedNCT02169310Phase 1
• Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected AdultsCompletedNCT02165267Phase 1
• Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)CompletedNCT02163122Early Phase 1
• Feasibility of Identifying a Chinese Study Population and Eligible Pediatric Cancer Cases, and Linking the Two Groups to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer.WithdrawnNCT02160795
• Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT02160015Phase 1
• Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell LymphomaActive, not recruitingNCT02159755Phase 1
• Characterization of the Pathogenesis of Primary and Secondary Lymphatic DisordersTerminatedNCT02156115
• Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study)CompletedNCT02156102
• Neuroimaging, Omega-3 and Reward in Adults With ADHD (NORAA) TrialTerminatedNCT02156089Phase 2
• EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung CancerCompletedNCT02154399Phase 2
• Clinical Autonomic Disorders: A Training ProtocolTerminatedNCT02154009
• Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United StatesTerminatedNCT02153996
• Calibration and Validation of the PROMIS and Neuro-QOL Questionnaires in Cerebral Palsy and Congenital Muscular DystrophyCompletedNCT02153970
• Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in Children Treated With Cranial Radiation for Brain TumorsCompletedNCT02153957Phase 2
• Internet Support Group for Parents of a Child With Neurofibromatosis Type 1CompletedNCT02153931
• Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying IntervalsCompletedNCT02151344Phase 1
• Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy PeopleCompletedNCT02147392Early Phase 1
• Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT02143401Phase 1
• Clinical Biomarkers in Alpha-mannosidosisCompletedNCT02141503
• Ask Suicide-Screening Questions to Everyone in Medical Settings (asQ em): Development of a Suicide Risk Screening Instrument for Adult Medical InpatientsCompletedNCT02140177

← National Institutes of Health overview and focus areas